stockrowNeoGenomics, Inc.
NEO Healthcare Diagnostics & Research
NeoGenomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $727.3 million, up 10.1% from fiscal 2024.
- Revenue
- +11.4%
- EPS
- +72.1%
- Free cash flow
- −3,724.2%
- Total debt
- +10.9%
Quarter to September 2026, against a year earlier
Follow NEO
Alert me
NeoGenomics, Inc. (NEO) Operating margin
NeoGenomics, Inc.'s operating margin over the twelve months to 30 September 2026 was −6.27%, up 9.7 percentage points from fiscal 2025 (−15.9%). Over the past ten years it has ranged from −30.9% (fiscal 2022) to 3.63% (fiscal 2018); the current reading is higher than 36% of that period. That is below the Diagnostics & Research industry median of −5.68% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −15.9% | (1.99) |
| FY2024 | −13.9% | 4.27 |
| FY2023 | −18.2% | 12.71 |
| FY2022 | −30.9% | (6.40) |
| FY2021 | −24.5% | (21.37) |
| FY2020 | −3.15% | (6.33) |
| FY2019 | 3.18% | (0.45) |
| FY2018 | 3.63% | 2.42 |
| FY2017 | 1.21% | 0.28 |
| FY2016 | 0.93% | 6.58 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −3.79% | 1.06 |
| Jun 2026 | −4.85% | 4.92 |
| Mar 2026 | −9.77% | (2.72) |
| Dec 2025 | −7.05% | 7.33 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| CDNA CareDx, Inc. compare | 23.4% |
| VCYT Veracyte, Inc. compare | 17.1% |
| FRNM Freenome, Inc compare | 0.00% |
| NEO NeoGenomics, Inc. | −6.27% |
| CSTL Castle Biosciences, Inc. compare | −7.43% |
| ADPT Adaptive Biotechnologies Corporation compare | −16.2% |
| WGS GeneDx Holdings Corp. compare | −20.3% |
| OPK OPKO Health, Inc. compare | −25.5% |
| PSNL Personalis, Inc. compare | −156.7% |
| Diagnostics & Research industry median | −5.68% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on NEO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement